Shikimic acid has been witnessing strong growth over the past few years on account of increasing demand from pharmaceutical and cosmetic industry. Shikimic acid is used as chiral binding block for the synthesis of wide range of pharmaceutical and cosmetic products. Increasing demand for cosmetic products, especially from female population, coupled with technological advancement in pharmaceutical industry is expected to surge the market growth over the next seven years. Shikimic acid is used as precursor for the synthesis of Tamiflu, the only drug to fight against avian flu (bird flu). Focus on shikimic acid has been increasing over the last few years owing to increasing number of avian flu victims across the globe. Shikimic acid is also used in the synthesis of bio-based products including aromatic amino acids. It is the key raw material used in production of oseltamivir phosphate, a potent viral inhibitor. Increasing demand for oseltamivir phosphate from agriculture sector is the key factor to drive shikimic acid demand over the forecast period. Shikimic acid is extracted from Illicium Anisatum plant, and limited availability of this plant is expected to hinder the market growth in near future.
Based on the plant species used for the extraction of shikimic acid, the market can be mainly segmented into calophyllum apetalum, pinanga dicksoni, garcinia morella, melia azedarach, and aegle marmelos. Shikimic acid extracted from calophyllum apetalum has been witnessing strong growth over the past few years on account of high composition of acid present.
Pharmaceutical industry was the largest end-use segment of shikimic acid in 2013 followed by cosmetics and fertilizer industries. The market is anticipated to witness significant growth in pharmaceutical segment owing to increasing application of shikimic acid in production of drugs related to flu. Rising flu across the globe has been increasing shikimic acid demand from pharmaceutical industries. In addition, increasing R&D activities in pharmaceutical industry to develop natural and bio-based drugs is expected to augment the market growth. Cosmetic industry was the second largest market for shikimic acid. Agriculture sector is also witnessing significant growth for shikimic acid market owing to increasing demand for oseltamivir phosphate, extensively used in the production of corn and soybeans.
Asia Pacific emerged as the largest market in 2013. China was the largest producer of shikimic acid in the world owing to huge availability of Illicium Anisatum, a Chinese medicinal plant, which is the key source for shikimic acid extraction. Most of the shikimic acid is consumed by Asia Pacific market owing to increasing diseases including bird flu in this region.
Key companies including Draths Corp. have been involved in R&D to improve the technologies related to shikimic acid extraction. Other players of shikimic acid market include Manus Aktteva Biopharma LLP, and Roche Holdings AG.
Avail customized purchase options to meet your research needs:
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.